CJC-1295 NO DAC (10 mg)

CJC-1295 (No DAC) is a synthetic peptide derived from Growth Hormone–Releasing Hormone (GHRH 1–29) and engineered without a Drug Affinity Complex (DAC). The absence of DAC results in a shorter duration of activity, making it distinct from the DAC-modified variant in research applications.

In laboratory studies, CJC-1295 (No DAC) has been examined for its interaction with growth hormone–related signaling pathways, particularly its ability to stimulate endogenous growth hormone release in controlled research settings. Its shorter half-life allows researchers to study pulsatile signaling patterns associated with growth hormone regulation.

CJC-1295 (No DAC) continues to be investigated in endocrine and metabolic research for its molecular behavior, receptor interactions, and downstream signaling mechanisms.